This inventor holds 1 USPTO granted patent. Top assignee: Laboratorios Salvat, S.a.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Natividad García Villar: Innovator in Apaf-1 Inhibitor Compounds
Introduction
Natividad García Villar is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of Apaf-1 inhibitor compounds. His work focuses on creating innovative solutions for medical conditions associated with apoptosis.
Latest Patents
Natividad holds 1 patent for his invention related to Apaf-1 inhibitor compounds. The patent describes derivatives of 2,5-piperazinedione that act as apoptotic peptidase activating factor 1 (Apaf-1) inhibitors. These compounds are valuable as active pharmaceutical ingredients for the prophylaxis and treatment of various pathological and physiological conditions linked to increased apoptosis.
Career Highlights
Natividad is currently associated with Laboratorios Salvat, S.A., where he continues to advance his research and development efforts. His work has the potential to impact the pharmaceutical industry significantly, providing new avenues for treatment.
Collaborations
Natividad collaborates with talented professionals in his field, including Ángel Messeguer Peypoch and Alejandra Moure Fernández. Their combined expertise enhances the innovative capacity of their projects.
Conclusion
Natividad García Villar is a pioneering inventor whose work on Apaf-1 inhibitors represents a significant advancement in pharmaceutical research. His contributions are poised to make a meaningful impact on medical treatments related to apoptosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile